LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: BMJ Publishing Group
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: cardiovascular diseases
The era of precision medicine has arrived and conveys tremendous potential, particularly for stroke neurology. The diagnosis of stroke, its underlying aetiology, theranostic strategies, recurrence risk and path to recovery are populated by a series of highly individualised questions. Moreover, the phenotypic complexity of a clinical diagnosis of stroke makes a simple genetic risk assessment only partially informative on an individual basis. The guiding principles of precision medicine in stroke underscore the need to identify, value, organise and analyse the multitude of variables obtained from each individual to generate a precise approach to optimise cerebrovascular health. Existing data may be leveraged with novel technologies, informatics and practical clinical paradigms to apply these principles in stroke and realise the promise of precision medicine. Importantly, precision medicine in stroke will only be realised once efforts to collect, value and synthesise the wealth of data collected in clinical trials and routine care starts. Stroke theranostics, the ultimate vision of synchronising tailored therapeutic strategies based on specific diagnostic data, demand cerebrovascular expertise on big data approaches to clinically relevant paradigms. This review considers such challenges and delineates the principles on a roadmap for rational application of precision medicine to stroke and cerebrovascular health.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med 2010;363(4):301-4.
    • 2. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015;372(9):793-5.
    • 3. Rostanski SK, Marshall RS. Precision Medicine for Ischemic Stroke. JAMA Neurol 2016;73(7):773-4.
    • 4. Feldmann E, Liebeskind DS. Developing precision stroke imaging. Front Neurol 2014;5:29.
    • 5. Liebeskind DS, Maholtra K, Hinman JD. Imaging as the Nidus. JAMA Neurol 2016;In Press.
    • 6. Liebeskind DS. Innovative Interventional and Imaging Registries: Precision Medicine in Cerebrovascular Disorders. Interv Neurol 2015;4(1-2):5-17.
    • 7. Kalaria RN. Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke 2012;43(9):2526-34.
    • 8. van Uden IW, van der Holst HM, Tuladhar AM, et al. White Matter and Hippocampal Volume Predict the Risk of Dementia in Patients with Cerebral Small Vessel Disease: The RUN DMC Study. J Alzheimers Dis 2015;49(3):863-73.
    • 9. Liebeskind DS, Feldmann E. Data considerations in ischemic stroke trials. Neurol Res 2014;36(5):423-6.
    • 10. Liebeskind DS, Feldmann E. Imaging of cerebrovascular disorders: precision medicine and the collaterome. Ann N Y Acad Sci 2016;1366(1):40-8.
    • 11. Liebeskind DS, Albers GW, Crawford K, et al. Imaging in StrokeNet: Realizing the Potential of Big Data. Stroke 2015;46(7):2000-6.
    • 12. Hunter DJ. Uncertainty in the Era of Precision Medicine. N Engl J Med 2016;375(8):711-3.
    • 13. Gong Y, Mu D, Prabhakar S, et al. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy. Mol Ther 2015;23(5):824-34.
    • 14. Traxler EA, Yao Y, Wang YD, et al. A genome-editing strategy to treat beta-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition. Nat Med 2016;22(9):987-90.
    • 15. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007;6(2):149-61.
    • 16. Falcone GJ, Malik R, Dichgans M, et al. Current concepts and clinical applications of stroke genetics. Lancet Neurol 2014;13(4):405-18.
    • 17. Sharma P, Meschia J, editors. Stroke Genetics. London: Springer-Verlag, 2013.
    • 18. Holliday EG, Traylor M, Malik R, et al. Genetic overlap between diagnostic subtypes of ischemic stroke. Stroke 2015;46(3):615-9.
    • 19. Sharp FR, Jickling GC, Stamova B, et al. Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. J Cereb Blood Flow Metab 2011;31(7):1513-31.
    • 20. Sharp FR, Jickling GC, Stamova B, et al. RNA expression profiles from blood for the diagnosis of stroke and its causes. J Child Neurol 2011;26(9):1131-6.
    • 21. Meschia JF. Pharmacogenetics and stroke. Stroke 2009;40(11):3641-5.
    • 22. Pare G, Eriksson N, Lehr T, et al. Genetic determinants of dabigatran plasma levels and their relation to bleeding. Circulation 2013;127(13):1404-12.
    • 23. del Rio-Espinola A, Fernandez-Cadenas I, Giralt D, et al. A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke. Ann Neurol 2012;72(5):716-29.
    • 24. Sealock R, Zhang H, Lucitti JL, et al. Congenic fine-mapping identifies a major causal locus for variation in the native collateral circulation and ischemic injury in brain and lower extremity. Circ Res 2014;114(4):660-71.
    • 25. Traylor M, Zhang CR, Adib-Samii P, et al. Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke. Neurology 2016;86(2):146-53.
    • 26. Cuadrado E, Rosell A, Colome N, et al. The proteome of human brain after ischemic stroke. J Neuropathol Exp Neurol 2010;69(11):1105-15.
    • 27. Ganz P, Heidecker B, Hveem K, et al. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease. JAMA 2016;315(23):2532-41.
    • 28. Ebinger M, Winter B, Wendt M, et al. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 2014;311(16):1622-31.
    • 29. Llombart V, Antolin-Fontes A, Bustamante A, et al. B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis. Stroke 2015;46(5):1187-95.
    • 30. Llombart V, Garcia-Berrocoso T, Bustamante A, et al. Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage. J Neurochem 2016;136(2):416-24.
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
    64
    64%
  • No similar publications.

Share - Bookmark

Funded by projects

  • NIH | MRI-GENetics Interface Expl...
  • NIH | Statins augment small vesse...
  • NIH | Modeling of Collateral Perf...

Cite this article